Sevoflurane preconditioning ameliorates neuronal deficits by inhibiting microglial MMP-9 expression after spinal cord ischemia/reperfusion in rats

Abstract

BackgroundMicroglia are the primary immune cells of the spinal cord that are activated in response to ischemia/reperfusion (IR) injury and release various neurotrophic and/or neurotoxic factors to determine neuronal survival. Among them, matrix metalloproteinase-9 (MMP-9), which cleaves various components of the extracellular matrix in the basal lamina and functions as part of the blood spinal cord barrier (BSCB), is considered important for regulating inflammatory responses and microenvironmental homeostasis of the BSCB in the pathology of ischemia. Sevoflurane has been reported to protect against neuronal apoptosis during cerebral IR. However, the effects of sevoflurane preconditioning on spinal cord IR injury remain unclear. In this study, we investigated the role of sevoflurane on potential genetic roles of microglial MMP-9 in tight junction protein breakdown, opening of the BSCB, and subsequent recruitment of microglia to apoptotic spinal cord neurons.ResultsThe results showed significant upregulation of MMP-9 in rats with IR-induced inflammation of the BSCB compared to that of the sham group, manifested as dysfunctional BSCB with increased Evans blue extravasation and reduced expression of occludin protein. Increased MMP-9 expression was also observed to facilitate invasion and migration of activated microglia, imaging as high Iba-1 expression, clustered to neurons in the injured spinal cord, as shown by double immunofluorescence, and increased proinflammatory chemokine production (CXCL10, CCL2). Further, sevoflurane preconditioning markedly improved motor function by ameliorating neuronal apoptosis, as shown by reduced TUNEL-positive cell counts and expression of cleaved caspase-3. These protective effects were probably responsible for downregulation of MMP-9 and maintenance of normal expression of occludin protein indicating BSCB integrity from inflammatory damage, which was confirmed by decreased protein levels of Iba-1 and MMP-9, as well as reduced production of proinflammatory chemokines (CXCL10, CCL2) and proinflammatory cytokines (IL-1β). Intrathecal injection of specific siRNAs targeting MMP-9 had similar protective effects to those of sevoflurane preconditioning.ConclusionsPreconditioning with 2.4% sevoflurane attenuated spinal cord IR injury by inhibiting recruitment of microglia and secretion of MMP-9; thus inhibiting downstream effects on inflammatory damage to BSCB integrity and neuronal apoptosis.Electronic supplementary materialThe online version of this article (doi:10.1186/s13041-014-0069-7) contains supplementary material, which is available to authorized users.

Role of autophagy in the bimodal stage after spinal cord ischemia reperfusion injury in rats

“…Similar to our previous studies (Fang et al, 2013a,b;Li et al, 2014a), the levels of TNF-a and IL-1b were significantly increased after I/R injury (P < 0.01; Fig. 5A, B).…”

Targeting the blood-spinal cord barrier: A therapeutic approach to spinal cord protection against ischemia-reperfusion injury

“…Bone marrow stromal stem cells, dexmedetomidine, ischemia, and sevoflurane preconditioning can downregulate MMP-9 expression and upregulate TJ proteins levels. This response can maintain the integrity of the BSCB and protect spinal cord [14,15,19,66]. MMP-9 is one of the main destructive factors for the BSCB.…”

Intrathecal l-arginine reduces the antinociception of sevoflurane in formalin-induced pain in rats

“…Many studies have shown that sevoflurane has analgesic properties and that its analgesic properties are mediated by the spinal cord [1,2]. However, the exact mechanisms and pathways of its anesthetic action are not clearly understood.…”